Bioline are pleased to be sponsoring and exhibiting at the 2nd qPCR and Digital PCR Congress in London, England on 20th and 21st October.
The meeting brings together key opinion leaders from industry and academia, and covers a range of important topics in real-time PCR, including:
Case studies in infectious diseases, vaccines, cancer, prenatal diagnosis, diagnostic and clinical applications, microbiology, food microbiology, plant and ecological genomics, as well as other novel applications will be presented.
A special session at the congress will be devoted to plant breeding, plant genomics and applied food and plant pathogen testing:
We will be showcasing our latest real-time PCR technological developments at the congress, including the new SensiFAST cDNA Synthesis Kit, a fast, easy-to-use method of generating the highest quality cDNA for highly accurate real-time PCR results.
Bioline will also be highlighting our industrial capabilities for custom manufacturing, including enzymes, buffer chemistries, dyes and internal controls for a wide range of applications from plant genotyping, agribiotech, pathogen testing and cancer research, to biomarkers and diagnostics research.
Our friendly team of real-time PCR specialists will be on-hand at our exhibition booth throughout the event and glad to answer your queries and discuss your research requirements.
For further details of speakers and topics, please see the Global Engage qPCR & Digital PCR Congress Agenda .
We look forward to seeing you at the 2014 congress.
Bioline is proud once again to offer its support to teams participating in the 2014 round of the annual iGEM competition. Teams supported by Bioline in previous years have won gold medals and advanced to the finals of the iGEM World Championships.
For a limited time only, all iGEM teams in the United Kingdom can take advantage of up to 40% off already highly-competitive Bioline list prices across our entire product range.
Popular tools used by successful iGEM teams around the world include:
We used bioline cells but didn’t follow the protocols because the cells were more competent so didn’t need to go through heat shock.— Boston iGEM 2012 Team
All Bioline products are backed by our friendly and helpful UK based technical support staff, should you need it!
To request full details of our Gem of an iGEM Offer pricing plan, please contact your local Bioline UK account manager using our Rep Finder tool. Then, why not let your fellow iGem researchers know about this great offer using the sharing links below. Also feel free to Tweet or email us if you have any further questions
We look forward to hearing from you soon and we wish all iGEM2014 entrants every success in this year's competition!
PS: You can also read about Bioline’s Synthetic Biology industry partnership with Liverpool Life Sciences UTC, the first school in the United Kingdom specialising in Science and Health Care for 14 to 19 year olds.
This offer is valid on any product in our range for any iGEM team in the United Kingdom. No minimum or maximum spend to qualify for the discount. Expires on October 31, 2014. Not valid with any other promo codes or special offers. Please contact us for details of discounts available to iGEM teams in the United States, Germany, France, Singapore and Australia. Bioline products are also available through our carefully selected distributor partners.
Are you a scientist at the leading edge of biological discovery? Then join Bioline at the Analytica International Trade Fair in Munich, April 1-4, 2014.
Visit us on stand 516 in Hall A3 to explore our research solutions for gene expression and genotyping studies. Discover how our innovative products help you to achieve better and more accurate results.
This year we’ll be showcasing our new products SensiFAST™ cDNA Synthesis Kit, the unmatched MyTaq™ Blood PCR Kit, and the latest addition to our range, EPIK™ Kits for Epigenetics research and analysis.
Four live talks a day at Analytica 2014
We'll be hosting live talks on the stand on all four days of the event, covering gene expression and cDNA synthesis, high-sensitivity qPCR, Bisulfite PCR, and all the latest innovations in Direct PCR.
Attend one of our talks most suited to your research, find out why Bioline is the perfect partner for your research, AND receive a free Bioline T-shirt!
We very much look forward to meeting with you at Analytica 2014!
Bioline: The PCR Company, a global leader in molecular biology innovation, will be exhibiting (Hall, 9, Stand D26) and presenting (Hall 9, Stand F69) at Europe's leading life science, biotechnology and laboratory show, BioTechnica 2013 (8-10 October, Hannover, Germany). Our Senior Global Product Manager, Dr. Steve Hawkins, will discuss the evolution of direct PCR amplification technologies as part of the prestigious Biotechnica Innovation Forum.
The recent increased focus on innovation in biotechnology and medical diagnostics within the world of life sciences has led to important advances in molecular detection and biomedicine. Bioline is proud to be at the forefront of some of the key developments in PCR technologies that are actively accelerating the pace and success of research for scientists around the world.
Molecular screening of blood samples for blood-borne pathogens, blood cell irregularities and blood group genotyping is a routinely performed process, but can be fraught with stumbling blocks. Some of the key concerns when using PCR to analyse DNA isolated from blood cells include the potential for false-negatives, or poor results that arise from a lack of sensitivity induced by the presence of PCR inhibitors in blood. Common reaction inhibitors include hemoglobin, IgG, lactoferrin, proteases, anticoagulants and salts.
Our presentation at the Biotechnica 2013 Innovation Forum is titled 'Fast PCR, Direct From Whole Blood, Without Compromise'. The talk will provide an overview of how technical challenges from direct PCR amplification of blood samples can be overcome using the very latest in direct PCR developments. We will outline an extremely rapid workflow that is specially engineered to overcome various PCR inhibitors typically present in whole blood samples that remove the need for pre-treatment or DNA isolation.
Ultra-fast PCR protocols specially developed to deliver significantly increased sensitivity and PCR success rates, without compromising quality and yield, will also be covered. We will also show how the speed and specificity of these techniques discussed make them the perfect solutions for performing high-throughput end-point multiplex PCR direct from whole blood.
Further details of our upcoming presentation at the Innovation Forum can be found on the Biotechnica 2013 web site.
Throughout the three days of Biotechnica 2013, we'll be presenting all the latest innovations across our endpoint-PCR and real-time PCR product lines. If you're attending, you'll find the brand new Bioline stand in Hall 9, Stand D26 where you will also be able to enter our iPad prize draw. We invite you to experience the power of the latest in life science innovation with Bioline and look forward to seeing you there.
Quantifying nucleic acids by Real-Time qPCR
4th-5th September 2013, Birkbeck, University of London
Register now for a two-day, hands-on workshop sponsored by Bioline: The PCR Company that teaches you the core principles of qPCR and focuses on the practical steps required to design, set-up, validate and analyse Real-Time qPCR assays.
The 6th International Meeting on Synthetic Biology (hashtag: #SB6Conf), the world’s foremost synthetic biology (SynBio) meeting, is currently running in London, organised by the BioBricks Foundation, a non-profit organization based in Cambridge, Massachusetts.
BioBricks Foundation SB6.0 Co-Chairs include Professor Paul Freemont and Professor Richard Kitney of Imperial College, who will lead a new £10 million innovation and knowledge centre, to be called SynbiCITE, aimed at providing a bridge between academia and industry and announced at the conference by David Willetts, Minister for Universities and Science.
Imperial College is home to the UK Centre for Synthetic Biology and Innovation a £9m investment aimed at propelling the synthetic biology field forward and promoting SynBio start-ups. International collaboration and networking are important aspects of the meeting, along with poster presentations and ‘lightning talks’ from world leaders in the field of SynBio research.
David Willets said:
"Synthetic biology has huge potential for our economy and society in so many areas, from life sciences to agriculture. But to realise this potential we need to ensure researchers and business work together. This new Innovation and Knowledge Centre will help advance scientific knowledge and turn cutting edge research into commercial success."
Professor Richard Kitney, co-academic of SynbiCITE added:
"Synthetic Biology could be the next ‘industrial revolution’ for the UK, where tiny devices manufactured from cells are used by us to improve many facets of our lives. From producing new, more sustainable fuels to developing devices that can monitor or improve our health, the applications in this field are limitless."
The exciting and emerging field of Synthetic Biology research combines the disciplines of engineering and molecular biology to design and build novel, biologically-based parts, devices, and sensors, as well as the re-engineering of existing, natural biological organisms. Synthetic Biology has the potential to deliver important new applications, from detecting the early onset of disease and improving existing industrial processes, food production, green fuels, and developing therapies to fight harmful bacterial infections or cancers.
Much of the future success of synthetic biology is incumbent upon the development of standardized SynBio components that can be combined in predictable and repeatable ways. The precise approach used when fabricating a BioBrick component depends on the fabrication method (PCR or direct synthesis) as well as the type of part being constructed (a standard part or protein coding sequence).
SyntheticBiology.org maintains a nice introduction to Synthetic Biology as well as a useful how-to guide on the subject of constructing novel BioBrick parts for submission to the Registry of Standard Biological Parts.
Bioline makes it easy to harness the power of new generation enzymes to create parts for BioBricks using PCR. We manufacture and supply a range of high-performance PCR and molecular biology cloning tools, enabling researchers to drive their synthetic biology projects forward. Some of our most popular, most frequently used products for leading synthetic biologists presenting at SB6.0 (1, 2) include the High-Fidelity Velocity DNA Polymerase, MyTaq HS DNA Polymerase for Colony-PCR, Competent Cells, Quick-Stick Ligase for TA Cloning, ISOLATE II Plasmid Mini Kits, and our acclaimed range of SensiMix™ and SensiFAST™ Real-Time PCR kits.
If you've been attending the #SB6Conf in London this week, let us know if your poster cites any Bioline reagents and your synthetic biology research work and achievements could be showcased in a forthcoming SynBio article on the Bioline blog. And if you’re one of the IGEMers attending the conference, don’t forget to check out our Gem of an offer for iGEM Teams!
One final note regarding the future of synthetic biology and the synthetic biologists of the future, you can keep up to date with all the latest news from the iGEM SynBio research teams around the world by following the international iGEM Teams Twitter list maintained by us @ThePCRCompany.
1. Giuraniuc CV, MacPherson M, Saka Y, et al. (2013). Gateway Vectors for Efficient Artificial Gene Assembly In Vitro and Expression in Yeast Saccharomyces cerevisiae. PLoS ONE 8(5): e64419. doi:10.1371/journal.pone.0064419
2. Ali H, Ries MI, Nijland JG, Lankhorst PP, Hankemeier T, et al. (2013). A Branched Biosynthetic Pathway Is Involved in Production of Roquefortine and Related Compounds in Penicillium chrysogenum. PLoS ONE 8(6): e65328. doi:10.1371/journal.pone.0065328
Bioline: The PCR Company and Medical Supply Company Ltd (MSC) of Dublin, Ireland are pleased to announce an exclusive partnership deal to deliver high-quality, high-performance Bioline reagents to hospitals, universities, technological institutes, industrial and pharmaceutical companies throughout Ireland.
From 9th July 2013, MSC becomes the exclusive distributor in the Republic of Ireland and Northern Ireland for the complete range of high-performance Bioline reagents and kits, with a focus on PCR and Real-Time PCR products. Eimear Scully, Managing Director of MSC commented:
Bioline has an excellent reputation for quality products and customer value, which closely matches our own values. MSC is committed to delivering the best solutions to meet the changing needs of our customers in each area we serve and we believe Bioline offers these quality solutions for PCR and Real-Time PCR."
Marco Calzavara, President of Bioline added:
"We are very excited with the appointment of MSC as this significantly expands our presence in Ireland through the expertise of MSC's team of highly qualified application specialists. We believe the partnership will enable scientists located in the leading Irish research centres to realize the benefits of our widely used PCR reagents."
From today MSC customers will have access to high-performance reagents and kits such as the proven SensiFAST™ Real-Time reagents, which offer the greatest sensitivity and fastest reaction times in Real-Time applications. MSC customers will also benefit from direct access to the highly-praised technical support services available from Bioline laboratory scientists.
Richard L. Eberly, President of Meridian Life Science, Inc., said:
We are delighted with the appointment of Medical Supply Company as our exclusive distributor for Bioline reagents and kits in Ireland. We chose MSC because of their commitment to customer service and technical expertise in the PCR area and we are confident this will result in delivering a world class service to our customers in Ireland."
For more information, please contact the Bioline office in London or:
Medical Supply Company Ltd.
Tel: +353 (0)1 822 4222
Fax: +353 (0)1 822 4100